These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22409419)

  • 1. Near-infrared imaging of veins in facial injection of botulinum toxin and hyaluronic acid.
    Blugerman G; Schavelzon D; Alvarez J
    Dermatol Surg; 2012 Jul; 38(7 Pt 2):1252-3. PubMed ID: 22409419
    [No Abstract]   [Full Text] [Related]  

  • 2. Injectable treatments for the aging face.
    Wise JB; Greco T
    Facial Plast Surg; 2006 May; 22(2):140-6. PubMed ID: 16847805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The shift toward minimally invasive aesthetic facial rejuvenation.
    Goldberg RA
    Arch Ophthalmol; 2010 Sep; 128(9):1200-1. PubMed ID: 20837806
    [No Abstract]   [Full Text] [Related]  

  • 5. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR; Julius H; Dunn M; Wilson F
    J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?
    Kapoor R; Shome D; Jain V; Dikshit R
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
    Carruthers J; Carruthers A; Monheit GD; Davis PG
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of the efficacy of low volume deep placement cheek injection vs. mid- to deep dermal nasolabial fold injection technique for the correction of nasolabial folds.
    Goodier M; Elm K; Wallander I; Zelickson B; Schram S
    J Cosmet Dermatol; 2014 Jun; 13(2):91-8. PubMed ID: 24910271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New trends in face rejuvenation by hyaluronic acid injections.
    Andre P
    J Cosmet Dermatol; 2008 Dec; 7(4):251-8. PubMed ID: 19146600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications in fillers and Botox.
    Niamtu J
    Oral Maxillofac Surg Clin North Am; 2009 Feb; 21(1):13-21, v. PubMed ID: 19185791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Scratched faces: treatment of dynamic facial wrinkles through the simultaneous combined use of botulinium toxin A and hyaluronic acid].
    Môle B
    Ann Chir Plast Esthet; 2012 Jun; 57(3):194-201. PubMed ID: 22401673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The minimal approach: an innovation in facial cosmetic procedures.
    de Maio M
    Aesthetic Plast Surg; 2004; 28(5):295-300. PubMed ID: 15529203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of treatment of melomental fold rhytides with cross-linked hyaluronic acid combined with onabotulinumtoxina and cross-linked hyaluronic acid alone.
    Custis T; Beynet D; Carranza D; Greco J; Lask GP; Kim J
    Dermatol Surg; 2010 Nov; 36 Suppl 3():1852-8. PubMed ID: 20969662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to the facial soft-tissue fillers conference supplement.
    Hanke CW
    J Am Acad Dermatol; 2011 Apr; 64(4 Suppl):S45-6. PubMed ID: 21458676
    [No Abstract]   [Full Text] [Related]  

  • 15. Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper face.
    Maas CS
    Facial Plast Surg Clin North Am; 2006 Aug; 14(3):241-5. PubMed ID: 16908391
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of headache relief with cosmetic onabotulinumtoxinA injections.
    Goldman ND; Dorton LH; Marcum KK; Gilbert RM; Sandoval LF
    J Cosmet Dermatol; 2014 Sep; 13(3):224-31. PubMed ID: 25196690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial Assessment and Injection Guide for Botulinum Toxin and Injectable Hyaluronic Acid Fillers: Focus on the Midface.
    de Maio M; DeBoulle K; Braz A; Rohrich RJ;
    Plast Reconstr Surg; 2017 Oct; 140(4):540e-550e. PubMed ID: 28953721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction.
    Sepehr A; Chauhan N; Alexander AJ; Adamson PA
    Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cosmetic eyelid and facial surgery.
    Ben Simon GJ; McCann JD
    Surv Ophthalmol; 2008; 53(5):426-42. PubMed ID: 18929758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the necessary practice competencies for two providers: dermal fillers and botulinum toxin type A injections?
    Spear M
    Plast Surg Nurs; 2010; 30(4):226-46; quiz 247-8. PubMed ID: 21217370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.